Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric T Fung

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2006
Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study populationLee E Moore, Eric T Fung, Marielena McGuire, et al.
Clinical Chemistry|February 17, 2007
Preanalytic influence of sample handling on SELDI-TOF serum protein profilesJohn F Timms, Elif Arslan-Low, Aleksandra Gentry-Maharaj, et al.
Clinical Chemistry|April 1, 2006
Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassayJin Song, Manisha Patel, C Nicole Rosenzweig, et al.
Cancer Investigation|May 1, 2013
Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancerIwona Podzielinski, Brook A Saunders, Kimberly D Kimbler, et al.
Proteomics. Clinical Applications|December 8, 2010
Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosisAnette Lykke Petri, Anja Hviid Simonsen, Estrid Høgdall, et al.
Circulation|August 29, 2007
Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studiesAndrew M Wilson, Eiichiro Kimura, Randall K Harada, et al.
Cancer Informatics|May 10, 2011
Reproducibility of SELDI Spectra Across Time and LaboratoriesLixia Diao, Charlotte H Clarke, Kevin R Coombes, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 23, 2025
Clinical Evaluation of Cancer Signal Origin Prediction and Diagnostic Resolution Following Multi-Cancer Early Detection Testing in the PATHFINDER StudyCatherine R Marinac, Charles H McDonnell, Lincoln D Nadauld, et al.
Lancet (London, England)|October 7, 2023
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort studyDeb Schrag, Tomasz M Beer, Charles H McDonnell, et al.
The Lancet. Oncology|January 16, 2025
Psychosocial impact associated with a multicancer early detection test (PATHFINDER): a prospective, multicentre, cohort studyLincoln Nadauld, Charles H McDonnell, Christina A Dilaveri, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2006
Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study populationLee E Moore, Eric T Fung, Marielena McGuire, et al.
Clinical Chemistry|February 17, 2007
Preanalytic influence of sample handling on SELDI-TOF serum protein profilesJohn F Timms, Elif Arslan-Low, Aleksandra Gentry-Maharaj, et al.
Clinical Chemistry|April 1, 2006
Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassayJin Song, Manisha Patel, C Nicole Rosenzweig, et al.
Cancer Investigation|May 1, 2013
Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancerIwona Podzielinski, Brook A Saunders, Kimberly D Kimbler, et al.
Proteomics. Clinical Applications|December 8, 2010
Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosisAnette Lykke Petri, Anja Hviid Simonsen, Estrid Høgdall, et al.
Circulation|August 29, 2007
Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studiesAndrew M Wilson, Eiichiro Kimura, Randall K Harada, et al.
Cancer Informatics|May 10, 2011
Reproducibility of SELDI Spectra Across Time and LaboratoriesLixia Diao, Charlotte H Clarke, Kevin R Coombes, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 23, 2025
Clinical Evaluation of Cancer Signal Origin Prediction and Diagnostic Resolution Following Multi-Cancer Early Detection Testing in the PATHFINDER StudyCatherine R Marinac, Charles H McDonnell, Lincoln D Nadauld, et al.
Lancet (London, England)|October 7, 2023
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort studyDeb Schrag, Tomasz M Beer, Charles H McDonnell, et al.
The Lancet. Oncology|January 16, 2025
Psychosocial impact associated with a multicancer early detection test (PATHFINDER): a prospective, multicentre, cohort studyLincoln Nadauld, Charles H McDonnell, Christina A Dilaveri, et al.
Pageof 6